{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:36:05Z","timestamp":1790033765200,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["12\/TIDA\/B2388"],"award-info":[{"award-number":["12\/TIDA\/B2388"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["BCNI,14\/ICS\/B3042"],"award-info":[{"award-number":["BCNI,14\/ICS\/B3042"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001593","name":"Irish Cancer Society","doi-asserted-by":"publisher","award":["BCNI,14\/ICS\/B3042"],"award-info":[{"award-number":["BCNI,14\/ICS\/B3042"]}],"id":[{"id":"10.13039\/501100001593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute myeloid leukaemia (AML) is an aggressive cancer with 50\u201375% of patients relapsing even after successful chemotherapy. The role of the bone marrow microenvironment (BMM) in protecting AML cells from chemotherapeutics and causing consequent relapse is increasingly recognised. However the role that the anti-apoptotic Bcl-2 proteins play as effectors of BMM-mediated drug resistance are less understood. Here we show that bone marrow mesenchymal stromal cells (BMSC) provide resistance to AML cells against BH<jats:sub>3<\/jats:sub>-mimetics, cytarabine and daunorubicin, but this is not mediated by Bcl-2 and\/or Bcl-X<jats:sub>L<\/jats:sub> as previously thought. Instead, BMSCs induced Mcl-1 expression over Bcl-2 and\/or Bcl-X<jats:sub>L<\/jats:sub> in AML cells and inhibition of Mcl-1 with a small-molecule inhibitor, A1210477, or repressing its expression with the CDC7\/CDK9 dual-inhibitor, PHA-767491 restored sensitivity to BH<jats:sub>3<\/jats:sub>-mimetics. Furthermore, combined inhibition of Bcl-2\/Bcl-X<jats:sub>L<\/jats:sub> and Mcl-1 could revert BMSC-mediated resistance against cytarabine + daunorubicin. Importantly, the CD34<jats:sup>+<\/jats:sup>\/CD38<jats:sup>\u2212<\/jats:sup> leukemic stem cell-encompassing population was equally sensitive to the combination of PHA-767491 and ABT-737. These results indicate that Bcl-2\/Bcl-X<jats:sub>L<\/jats:sub> and Mcl-1 act in a redundant fashion as effectors of BMM-mediated AML drug resistance and highlight the potential of Mcl-1-repression to revert BMM-mediated drug resistance in the leukemic stem cell population, thus, prevent disease relapse and ultimately improve patient survival.<\/jats:p>","DOI":"10.1038\/s41598-018-33982-y","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T09:19:37Z","timestamp":1539940777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Repression of Mcl-1 expression by the CDC7\/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML"],"prefix":"10.1038","volume":"8","author":[{"given":"Eimear","family":"O\u2019 Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhraj Pal S.","family":"Dhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis V.","family":"Baev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Ortutay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Halpin-McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-5656","authenticated-orcid":false,"given":"Corrado","family":"Santocanale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-8375","authenticated-orcid":false,"given":"Afshin","family":"Samali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"O\u2019Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-3535","authenticated-orcid":false,"given":"Eva","family":"Szegezdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"33982_CR1","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ajh.23498","volume":"88","author":"C Sarkozy","year":"2013","unstructured":"Sarkozy, C. et al. Outcome of older patients with acute myeloid leukemia in first relapse. American journal of hematology 88, 758\u2013764, https:\/\/doi.org\/10.1002\/ajh.23498 (2013).","journal-title":"American journal of hematology"},{"key":"33982_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","volume":"29","author":"A Burnett","year":"2011","unstructured":"Burnett, A., Wetzler, M. & Lowenberg, B. Therapeutic advances in acute myeloid leukemia. J Clin Oncol 29, 487\u2013494, https:\/\/doi.org\/10.1200\/JCO.2010.30.1820 (2011).","journal-title":"J Clin Oncol"},{"key":"33982_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1532\/IJH97.04094","volume":"80","author":"B Ruter","year":"2004","unstructured":"Ruter, B., Wijermans, P. W. & Lubbert, M. DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia. Int J Hematol 80, 128\u2013135 (2004).","journal-title":"Int J Hematol"},{"issue":"Suppl 1","key":"33982_CR4","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.ctrv.2011.04.013","volume":"37","author":"T Schoofs","year":"2011","unstructured":"Schoofs, T. & Muller-Tidow, C. DNA methylation as a pathogenic event and as a therapeutic target in AML. Cancer Treat Rev 37(Suppl 1), S13\u201318, https:\/\/doi.org\/10.1016\/j.ctrv.2011.04.013 (2011).","journal-title":"Cancer Treat Rev"},{"key":"33982_CR5","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1158\/1535-7163.MCT-06-0228","volume":"5","author":"Z Zeng","year":"2006","unstructured":"Zeng, Z. et al. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther 5, 3113\u20133121, https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0228 (2006).","journal-title":"Mol Cancer Ther"},{"key":"33982_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1182\/blood-2004-02-0566","volume":"104","author":"EJ Rombouts","year":"2004","unstructured":"Rombouts, E. J., Pavic, B., Lowenberg, B. & Ploemacher, R. E. Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood 104, 550\u2013557, https:\/\/doi.org\/10.1182\/blood-2004-02-0566 (2004).","journal-title":"Blood"},{"key":"33982_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.exphem.2006.01.013","volume":"34","author":"JP Veiga","year":"2006","unstructured":"Veiga, J. P., Costa, L. F., Sallan, S. E., Nadler, L. M. & Cardoso, A. A. Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival. Exp Hematol 34, 610\u2013621, https:\/\/doi.org\/10.1016\/j.exphem.2006.01.013 (2006).","journal-title":"Exp Hematol"},{"key":"33982_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.leu.2402608","volume":"16","author":"M Konopleva","year":"2002","unstructured":"Konopleva, M. et al. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 16, 1713\u20131724, https:\/\/doi.org\/10.1038\/sj.leu.2402608 (2002).","journal-title":"Leukemia"},{"key":"33982_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.coi.2007.06.002","volume":"19","author":"JT Opferman","year":"2007","unstructured":"Opferman, J. T. Life and death during hematopoietic differentiation. Curr Opin Immunol 19, 497\u2013502, https:\/\/doi.org\/10.1016\/j.coi.2007.06.002 (2007).","journal-title":"Curr Opin Immunol"},{"key":"33982_CR10","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2004-11-4344","volume":"106","author":"MM Rhodes","year":"2005","unstructured":"Rhodes, M. M., Kopsombut, P., Bondurant, M. C., Price, J. O. & Koury, M. J. Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin. Blood 106, 1857\u20131863, https:\/\/doi.org\/10.1182\/blood-2004-11-4344 (2005).","journal-title":"Blood"},{"key":"33982_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1182\/blood-2002-11-3324","volume":"102","author":"W Aerbajinai","year":"2003","unstructured":"Aerbajinai, W., Giattina, M., Lee, Y. T., Raffeld, M. & Miller, J. L. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. Blood 102, 712\u2013717, https:\/\/doi.org\/10.1182\/blood-2002-11-3324 (2003).","journal-title":"Blood"},{"key":"33982_CR12","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/cdd.2012.88","volume":"19","author":"T Kodama","year":"2012","unstructured":"Kodama, T. et al. Mcl-1 and Bcl-xL regulate Bak\/Bax-dependent apoptosis of the megakaryocytic lineage at multistages. Cell Death and Differentiation 19, 1856\u20131869, https:\/\/doi.org\/10.1038\/cdd.2012.88 (2012).","journal-title":"Cell Death and Differentiation"},{"key":"33982_CR13","doi-asserted-by":"crossref","unstructured":"Zhang, H. et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 14, 943\u2013951, http:\/\/www.nature.com\/cdd\/journal\/v14\/n5\/suppinfo\/4402081s1.html, (2007).","DOI":"10.1038\/sj.cdd.4402081"},{"key":"33982_CR14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1189\/jlb.70.5.783","volume":"70","author":"DA Moulding","year":"2001","unstructured":"Moulding, D. A., Akgul, C., Derouet, M., White, M. R. & Edwards, S. W. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J Leukoc Biol 70, 783\u2013792 (2001).","journal-title":"J Leukoc Biol"},{"key":"33982_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","volume":"4","author":"R Pan","year":"2014","unstructured":"Pan, R. et al. Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia. Cancer Discov 4, 362\u2013375, https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0609 (2014).","journal-title":"Cancer Discov"},{"key":"33982_CR16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/leu.2014.44","volume":"28","author":"JM Bogenberger","year":"2014","unstructured":"Bogenberger, J. M. et al. BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies. Leukemia 28, 1657\u20131665, https:\/\/doi.org\/10.1038\/leu.2014.44 (2014).","journal-title":"Leukemia"},{"key":"33982_CR17","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/sj.leu.2404776","volume":"21","author":"TM Kohl","year":"2007","unstructured":"Kohl, T. M. et al. BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts. Leukemia 21, 1763\u20131772, https:\/\/doi.org\/10.1038\/sj.leu.2404776 (2007).","journal-title":"Leukemia"},{"key":"33982_CR18","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1073\/pnas.1104778108","volume":"109","author":"SR Oakes","year":"2012","unstructured":"Oakes, S. R. et al. Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737. Proc Natl Acad Sci USA 109, 2766\u20132771, https:\/\/doi.org\/10.1073\/pnas.1104778108 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"33982_CR19","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1182\/blood-2011-06-364182","volume":"119","author":"JM Gerber","year":"2012","unstructured":"Gerber, J. M. et al. A clinically relevant population of leukemic CD34(+)CD38(\u2212) cells in acute myeloid leukemia. Blood 119, 3571\u20133577, https:\/\/doi.org\/10.1182\/blood-2011-06-364182 (2012).","journal-title":"Blood"},{"key":"33982_CR20","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1158\/0008-5472.can-14-3379","volume":"75","author":"JA Kim","year":"2015","unstructured":"Kim, J. A. et al. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia. Cancer Res. 75, 2222\u20132231, https:\/\/doi.org\/10.1158\/0008-5472.can-14-3379 (2015).","journal-title":"Cancer Res."},{"key":"33982_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1749-6632.1999.tb08461.x","volume":"872","author":"B Torok-Storb","year":"1999","unstructured":"Torok-Storb, B. et al. Dissecting the marrow microenvironment. Ann N Y Acad Sci 872, 164\u2013170 (1999).","journal-title":"Ann N Y Acad Sci"},{"key":"33982_CR22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V58.6.1203.1203","volume":"58","author":"KR Rai","year":"1981","unstructured":"Rai, K. R. et al. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood 58, 1203\u20131212 (1981).","journal-title":"Blood"},{"key":"33982_CR23","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1073\/pnas.0400782101","volume":"101","author":"AI Su","year":"2004","unstructured":"Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101, 6062\u20136067, https:\/\/doi.org\/10.1073\/pnas.0400782101 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"33982_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1101\/gad.182980.111","volume":"26","author":"SP Glaser","year":"2012","unstructured":"Glaser, S. P. et al. Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes Dev 26, 120\u2013125, https:\/\/doi.org\/10.1101\/gad.182980.111 (2012).","journal-title":"Genes Dev"},{"key":"33982_CR25","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1158\/1535-7163.MCT-10-1119","volume":"10","author":"A Natoni","year":"2011","unstructured":"Natoni, A. et al. Mechanisms of action of a dual Cdc7\/Cdk9 kinase inhibitor against quiescent and proliferating CLL cells. Mol Cancer Ther 10, 1624\u20131634, https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-1119 (2011).","journal-title":"Mol Cancer Ther"},{"key":"33982_CR26","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1182\/blood-2009-07-233304","volume":"115","author":"D Yecies","year":"2010","unstructured":"Yecies, D., Carlson, N. E., Deng, J. & Letai, A. Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood 115, 3304\u20133313, https:\/\/doi.org\/10.1182\/blood-2009-07-233304 (2010).","journal-title":"Blood"},{"key":"33982_CR27","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1021\/jm501258m","volume":"58","author":"M Bruncko","year":"2015","unstructured":"Bruncko, M. et al. Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity. J. Med. Chem. 58, 2180\u20132194, https:\/\/doi.org\/10.1021\/jm501258m (2015).","journal-title":"J. Med. Chem."},{"key":"33982_CR28","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.celrep.2016.02.039","volume":"14","author":"S Grabow","year":"2016","unstructured":"Grabow, S., Delbridge, A. R., Aubrey, B. J., Vandenberg, C. J. & Strasser, A. Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis. Cell Rep 14, 2337\u20132347, https:\/\/doi.org\/10.1016\/j.celrep.2016.02.039 (2016).","journal-title":"Cell Rep"},{"key":"33982_CR29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood.V124.21.118.118","volume":"124","author":"M Konopleva","year":"2014","unstructured":"Konopleva, M. et al. A Phase 2 Study of ABT-199 (GDC-0199) in Patients with Acute Myelogenous Leukemia (AML). Blood 124, 118\u2013118 (2014).","journal-title":"Blood"},{"key":"33982_CR30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood.V84.2.595.595","volume":"84","author":"L Campos","year":"1994","unstructured":"Campos, L., Sabido, O., Rouault, J. P. & Guyotat, D. Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood 84, 595\u2013600 (1994).","journal-title":"Blood"},{"key":"33982_CR31","doi-asserted-by":"publisher","first-page":"e0138377","DOI":"10.1371\/journal.pone.0138377","volume":"10","author":"J Ishizawa","year":"2015","unstructured":"Ishizawa, J. et al. Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs. PLoS One 10, e0138377, https:\/\/doi.org\/10.1371\/journal.pone.0138377 (2015).","journal-title":"PLoS One"},{"key":"33982_CR32","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1046\/j.1365-2141.2001.02603.x","volume":"112","author":"DA Fennell","year":"2001","unstructured":"Fennell, D. A., Corbo, M. V., Dean, N. M., Monia, B. P. & Cotter, F. E. In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID\/NOD-Hu model. Br J Haematol 112, 706\u2013713 (2001).","journal-title":"Br J Haematol"},{"key":"33982_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0301-472X(01)00612-9","volume":"29","author":"SM Garrido","year":"2001","unstructured":"Garrido, S. M., Appelbaum, F. R., Willman, C. L. & Banker, D. E. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp Hematol 29, 448\u2013457 (2001).","journal-title":"Exp Hematol"},{"key":"33982_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1126\/science.1106114","volume":"307","author":"JT Opferman","year":"2005","unstructured":"Opferman, J. T. et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 307, 1101\u20131104, https:\/\/doi.org\/10.1126\/science.1106114 (2005).","journal-title":"Science"},{"key":"33982_CR35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood.V91.3.991","volume":"91","author":"SH Kaufmann","year":"1998","unstructured":"Kaufmann, S. H. et al. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood 91, 991\u20131000 (1998).","journal-title":"Blood"},{"key":"33982_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.525","volume":"6","author":"GS Choudhary","year":"2015","unstructured":"Choudhary, G. S. et al. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies. Cell Death Dis 6, e1593, https:\/\/doi.org\/10.1038\/cddis.2014.525 (2015).","journal-title":"Cell Death Dis"},{"key":"33982_CR37","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1182\/blood-2011-03-340364","volume":"118","author":"S Al-Harbi","year":"2011","unstructured":"Al-Harbi, S. et al. An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737. Blood 118, 3579\u20133590, https:\/\/doi.org\/10.1182\/blood-2011-03-340364 (2011).","journal-title":"Blood"},{"key":"33982_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2012.5","volume":"2","author":"S Kasper","year":"2012","unstructured":"Kasper, S. et al. Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies. Blood Cancer J 2, e60, https:\/\/doi.org\/10.1038\/bcj.2012.5 (2012).","journal-title":"Blood Cancer J"},{"issue":"8","key":"33982_CR39","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4161\/cbt.29186","volume":"15","author":"Kenichiro Doi","year":"2014","unstructured":"Doi, K. et al. Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression. Cancer Biol Ther 15 (2014).","journal-title":"Cancer Biology & Therapy"},{"key":"33982_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0014-5793(00)01809-3","volume":"478","author":"C Akgul","year":"2000","unstructured":"Akgul, C., Moulding, D. A., White, M. R. & Edwards, S. W. In vivo localisation and stability of human Mcl-1 using green fluorescent protein (GFP) fusion proteins. FEBS Lett 478, 72\u201376 (2000).","journal-title":"FEBS Lett"},{"key":"33982_CR41","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1517\/13543784.2011.609167","volume":"20","author":"BA Quinn","year":"2011","unstructured":"Quinn, B. A. et al. Targeting Mcl-1 for the therapy of cancer. Expert Opin Investig Drugs 20, 1397\u20131411, https:\/\/doi.org\/10.1517\/13543784.2011.609167 (2011).","journal-title":"Expert Opin Investig Drugs"},{"key":"33982_CR42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2174\/156652408783769580","volume":"8","author":"MR Warr","year":"2008","unstructured":"Warr, M. R. & Shore, G. C. Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med 8, 138\u2013147 (2008).","journal-title":"Curr Mol Med"},{"key":"33982_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nchembio.90","volume":"4","author":"A Montagnoli","year":"2008","unstructured":"Montagnoli, A. et al. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity. Nat Chem Biol 4, 357\u2013365, https:\/\/doi.org\/10.1038\/nchembio.90 (2008).","journal-title":"Nat Chem Biol"},{"key":"33982_CR44","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1128\/MCB.20.8.2629-2634.2000","volume":"20","author":"DH Price","year":"2000","unstructured":"Price, D. H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 20, 2629\u20132634 (2000).","journal-title":"Mol Cell Biol"},{"key":"33982_CR45","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/aps.2016.49","volume":"37","author":"S Xie","year":"2016","unstructured":"Xie, S. et al. Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells. Acta Pharmacol. Sin. 37, 1481, https:\/\/doi.org\/10.1038\/aps.2016.49 (2016).","journal-title":"Acta Pharmacol. Sin."},{"key":"33982_CR46","doi-asserted-by":"publisher","first-page":"107206","DOI":"10.18632\/oncotarget.22284","volume":"8","author":"J Bogenberger","year":"2017","unstructured":"Bogenberger, J. et al. Combined venetoclax and alvocidib in acute myeloid leukemia. Oncotarget 8, 107206\u2013107222, https:\/\/doi.org\/10.18632\/oncotarget.22284 (2017).","journal-title":"Oncotarget"},{"key":"33982_CR47","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/ijc.29009","volume":"136","author":"G Polier","year":"2014","unstructured":"Polier, G. et al. Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263. Int. J. Cancer 136, 688\u2013698, https:\/\/doi.org\/10.1002\/ijc.29009 (2014).","journal-title":"Int. J. Cancer"},{"key":"33982_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/leu.2015.179","volume":"30","author":"S Jilg","year":"2016","unstructured":"Jilg, S. et al. Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients. Leukemia 30, 112\u2013123, https:\/\/doi.org\/10.1038\/leu.2015.179 (2016).","journal-title":"Leukemia"},{"key":"33982_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2014.05.019","volume":"26","author":"H-J Lee","year":"2014","unstructured":"Lee, H.-J. et al. Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells. Cancer Cell 26, 207\u2013221, https:\/\/doi.org\/10.1016\/j.ccr.2014.05.019 (2014).","journal-title":"Cancer Cell"},{"key":"33982_CR50","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1182\/blood-2015-01-621250","volume":"125","author":"AR Delbridge","year":"2015","unstructured":"Delbridge, A. R., Opferman, J. T., Grabow, S. & Strasser, A. Antagonism between MCL-1 and PUMA governs stem\/progenitor cell survival during hematopoietic recovery from stress. Blood 125, 3273\u20133280, https:\/\/doi.org\/10.1182\/blood-2015-01-621250 (2015).","journal-title":"Blood"},{"key":"33982_CR51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molcel.2010.04.012","volume":"38","author":"B Sobhian","year":"2010","unstructured":"Sobhian, B. et al. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol Cell 38, 439\u2013451, https:\/\/doi.org\/10.1016\/j.molcel.2010.04.012 (2010).","journal-title":"Mol Cell"},{"key":"33982_CR52","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","volume":"37","author":"C Lin","year":"2010","unstructured":"Lin, C. et al. AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 37, 429\u2013437, https:\/\/doi.org\/10.1016\/j.molcel.2010.01.026 (2010).","journal-title":"Mol Cell"},{"key":"33982_CR53","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","volume":"110","author":"D Mueller","year":"2007","unstructured":"Mueller, D. et al. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 110, 4445\u20134454, https:\/\/doi.org\/10.1182\/blood-2007-05-090514 (2007).","journal-title":"Blood"},{"key":"33982_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1097-2765(01)00314-8","volume":"8","author":"M Barboric","year":"2001","unstructured":"Barboric, M., Nissen, R. M., Kanazawa, S., Jabrane-Ferrat, N. & Peterlin, B. M. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell 8, 327\u2013337 (2001).","journal-title":"Mol Cell"},{"key":"33982_CR55","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.neo.2014.10.002","volume":"16","author":"K Balakrishnan","year":"2014","unstructured":"Balakrishnan, K. et al. Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia. Neoplasia 16, 1036\u20131046, https:\/\/doi.org\/10.1016\/j.neo.2014.10.002 (2014).","journal-title":"Neoplasia"},{"key":"33982_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.lrr.2014.06.001","volume":"3","author":"DV Baev","year":"2014","unstructured":"Baev, D. V., Krawczyk, J., O\u2019Dwyer, M. & Szegezdi, E. The BH3-mimetic ABT-737 effectively kills acute myeloid leukemia initiating cells. Leukemia Research Reports 3, 79\u201382, https:\/\/doi.org\/10.1016\/j.lrr.2014.06.001 (2014).","journal-title":"Leukemia Research Reports"},{"key":"33982_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/gcc.20500","volume":"47","author":"DL Stirewalt","year":"2008","unstructured":"Stirewalt, D. L. et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes, Chromosomes and Cancer 47, 8\u201320, https:\/\/doi.org\/10.1002\/gcc.20500 (2008).","journal-title":"Genes, Chromosomes and Cancer"},{"issue":"7","key":"33982_CR58","doi-asserted-by":"publisher","first-page":"e702","DOI":"10.1038\/cddis.2013.214","volume":"4","author":"M van Dijk","year":"2013","unstructured":"van Dijk, M., Halpin-McCormick, A., Sessler, T., Samali, A. & Szegezdi, E. Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways. Cell Death & Amp; Disease 4, e702, https:\/\/doi.org\/10.1038\/cddis.2013.214 https:\/\/www.nature.com\/articles\/cddis2013214#supplementary-information, (2013).","journal-title":"Cell Death & Disease"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33982-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33982-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33982-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:43:06Z","timestamp":1671619386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33982-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33982"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33982-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"10 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15752"}}